Journal of Clinical Endocrinology & Metabolism, Vol 79, 848-853, Copyright © 1994 by Endocrine Society

ARTICLES

Multiple sclerosis is associated with alterations in hypothalamic- pituitary-adrenal axis function

D Michelson, L Stone, E Galliven, MA Magiakou, GP Chrousos, EM Sternberg and PW Gold
Clinical Neuroendocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892.

In the LEW/N rat model, a decreased hypothalamic-pituitary-adrenal (HPA) axis response to inflammatory and immune mediators confers susceptibility to the development of a variety of inflammatory and immune diseases, including experimental allergic encephalomyelitis. In humans with optic neuritis, early intervention with steroids is associated with a decrease in the number of patients who go on to develop multiple sclerosis (MS). The current study was designed to determine whether patients with MS show evidence of a hypoactive HPA axis. Thirteen patients with MS were studied at baseline and with provocative tests of HPA axis function [ovine CRH, arginine vasopressin (AVP), and ACTH stimulation]. Compared to matched controls, patients with MS had significantly higher plasma cortisol levels at baseline. Despite this hypercortisolism and in contrast to patients with depression who had similar elevations in plasma cortisol levels, patients with MS showed normal, rather than blunted, plasma ACTH responses to ovine CRH, suggesting that the pathophysiology of hypercortisolism in MS is different from that in depression. Patients with MS also showed blunted ACTH responses to AVP stimulation and normal cortisol responses to high and low dose ACTH stimulation. Taken together, these findings are compatible with data from studies of experimental animals exposed to chronic inflammatory stress, which showed mild increased activation of the HPA axis with increased relative activity of AVP in the regulation of the pituitary-adrenal axis. These data do not support a role for hypocortisolism in MS once the disease is established.

This article has been cited by other articles:

				N. L. Sicotte, K. C. Kern, B. S. Giesser, A. Arshanapalli, A. Schultz, M. Montag, H. Wang, and S. Y. Bookheimer Regional hippocampal atrophy in multiple sclerosis Brain, April 1, 2008; 131(4): 1134 - 1141. [Abstract] [Full Text] [PDF]

				S. Kern and T. Ziemssen Review: Brain immune communication psychoneuroimmunology of multiple sclerosis Multiple Sclerosis, January 1, 2008; 14(1): 6 - 21. [Abstract] [PDF]

				K. Jefferies The neuropsychiatry of multiple sclerosis Advan. Psychiatr. Treat., May 1, 2006; 12(3): 214 - 220. [Abstract] [Full Text] [PDF]

				L. M. L. van Winsen, D. F. R. Muris, C. H. Polman, C. D. Dijkstra, T. K. van den Berg, and B. M. J. Uitdehaag Sensitivity to Glucocorticoids Is Decreased in Relapsing Remitting Multiple Sclerosis J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 734 - 740. [Abstract] [Full Text] [PDF]

				A. Beishuizen and L. G. Thijs Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis Innate Immunity, February 1, 2003; 9(1): 3 - 24. [Abstract] [PDF]

				Z A Erkut, E Endert, I Huitinga, and D F Swaab Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis Multiple Sclerosis, June 1, 2002; 8(3): 229 - 236. [Abstract] [PDF]

				F. T. Bergh, T. Kümpfel, A. Grasser, R. Rupprecht, F. Holsboer, and C. Trenkwalder Combined Treatment with Corticosteroids and Moclobemide Favors Normalization of Hypothalamo-Pituitary-Adrenal Axis Dysregulation in Relapsing-Remitting Multiple Sclerosis: A Randomized, Double Blind Trial J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1610 - 1615. [Abstract] [Full Text]

				F. T. Bergh, T. Kumpfel, C. Trenkwalder, R. Rupprecht, and F. Holsboer Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS Neurology, September 1, 1999; 53(4): 772 - 772. [Abstract] [Full Text] [PDF]

				J. R. Chan, L. J. Phillips II, and M. Glaser Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation PNAS, September 1, 1998; 95(18): 10459 - 10464. [Abstract] [Full Text] [PDF]

				Z. A. Erkut, C. Pool, and D. F. Swaab Glucocorticoids Suppress Corticotropin-Releasing Hormone and Vasopressin Expression in Human Hypothalamic Neurons J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2066 - 2073. [Abstract] [Full Text]

				G. P. Chrousos Editorial: Ultradian, Circadian, and Stress-Related Hypothalamic-Pituitary-Adrenal Axis Activity--A Dynamic Digital-to-Analog Modulation Endocrinology, February 1, 1998; 139(2): 437 - 440. [Full Text] [PDF]

				K. Fassbender, R. Schmidt, R. Mossner, U. Kischka, J. Kuhnen, A. Schwartz, and M. Hennerici Mood Disorders and Dysfunction of the Hypothalamic-Pituitary-Adrenal Axis in Multiple Sclerosis: Association With Cerebral Inflammation Arch Neurol, January 1, 1998; 55(1): 66 - 72. [Abstract] [Full Text] [PDF]

				J. S. Petrides, P. W. Gold, G. P. Mueller, A. Singh, C. Stratakis, G. P. Chrousos, and P. A. Deuster Marked differences in functioning of the hypothalamicpituitary-adrenal axis between groups of men J Appl Physiol, June 1, 1997; 82(6): 1979 - 1988. [Abstract] [Full Text] [PDF]